FDA AND REGULATORY

IVDR transition and EUDAMED: two timelines to track

Original source: IVDR transition and EUDAMED: two timelines to track

Original source publication date:

Conditional transition periods and database obligations answer different compliance questions.

The transition dates

Regulation (EU) 2024/1860 extends eligible legacy-device transitions to 31 December 2027 for IVDD-certified and class D devices; 31 December 2028 for class C; and 31 December 2029 for class B and class A sterile. Eligibility is conditional, including continued IVDD compliance, no significant design or intended-purpose change, acceptable risk, an IVDR quality system by 26 May 2025, and timely notified-body application and agreement.

A separate database milestone

The European Commission states that four EUDAMED modules became mandatory on 28 May 2026: actor registration, UDI/device registration, notified bodies/certificates, and market surveillance. Responsibilities differ by actor; the market-surveillance module concerns authorities.

Turn dates into responsibilities

A useful planning exercise is to maintain separate records for transition eligibility and database obligations. Assign an owner, supporting evidence and a review date to each relevant requirement. A future transition end date should not be interpreted as permission to postpone every earlier obligation.

Sources & further reading

Read the original company post on LinkedInRegulation (EU) 2024/1860European Commission — mandatory EUDAMED modules

Adapted from a public company post, with sources checked on 8 October 2026. Original post dates are preserved; the website summary is not attributed to an individual employee.

Back to all resources
CONTACT HMC

Discuss your study
or regulatory submission.

Tell us your product type, target market,
and the support you need.

Contact HMC
Hands using an office telephone, from the original HMC website

Ready to learn more about working with us?

CONTACT USCHAT WITH US